Company Information
Ask for more detail from the seller
Contact SupplierDarbepoetin alfa (rINN) /dテラテッツソツステルテッツソツスrbテラテッツソツステルテッツソツスpテラテッツソツステラテつェtテδ。テつオテつサn/ is a synthetic form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy. Darbepoetin is marketed by Amgen under the trade name Aranesp.
The drug was approved in September 2001 by the Food and Drug Administration for treatment of anemia in patients with chronic renal failure by intravenous or subcutaneous injection.It had been approved by the European Medicines Agency for this indication as well as the treatment of anemia in cancer patients undergoing chemotherapy.